22 results
8-K
EX-99.2
PCSA
Processa Pharmaceuticals Inc
1 Jun 20
Entry into a Material Definitive Agreement
7:01am
obtaining the approval of the Israel Innovation Authority for the consummation of the transactions set forth in the agreement. Subject to the terms
8-K
EX-99.1
PCSA
Processa Pharmaceuticals Inc
9 Jul 13
Regulation FD Disclosure
12:00am
, device, or other innovation that has been adopted by at least one agency, is market ready and is available for use by other interested agencies.
Guided
8-K
nrg pom9bppbhnt
12 Oct 17
Entry into a Material Definitive Agreement
12:00am
424B4
1bym1s9nb1shel7fp7
5 Oct 20
Prospectus supplement with pricing info
4:16pm